The 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) is taking place in Kuala Lumpur, Malaysia, later this month.;

Read more >

A recent NAM survey shows that people living with HIV in the UK understand why branded HIV drugs might be changed for generic versions, and are sympathetic to the need for cost savings. However, respondents would be uncomfortable with a switch to generics if it meant a reduction in how well their HIV treatment worked, resulted in new side-effects or food restrictions, or meant they had to take doses more frequently.;

Read more >

As part of its European HIV prevention work, NAM is collaborating with AVAC to provide a series of webinars (conference calls with accompanying slides) to train and inform prevention advocates and anyone interested in the newest developments in HIV prevention technology.;

Read more >

There’s been lots of interest recently in the concept of shared decision making – and there’s plenty of evidence that people who are actively involved in decisions about their health care see the benefits. When people are well informed and engage with choosing and planning their care both patients and health services benefit.;

Read more >

As part of its European HIV prevention work, NAM is collaborating with AVAC to provide a series of webinars (conference calls with accompanying slides) to train and inform prevention advocates and anyone interested in the newest developments in HIV prevention technology.;

Read more >